These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15915620)

  • 1. Clandestine drug laboratories in Australia and the potential for harm.
    Caldicott DG; Pigou PE; Beattie R; Edwards JW
    Aust N Z J Public Health; 2005 Apr; 29(2):155-62. PubMed ID: 15915620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposures associated with clandestine methamphetamine drug laboratories in Australia.
    Wright J; Edwards J; Walker S
    Rev Environ Health; 2016 Sep; 31(3):329-52. PubMed ID: 27428841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of methamphetamine exposure in children removed from clandestine methamphetamine laboratories.
    Grant P; Bell K; Stewart D; Paulson J; Rogers K
    Pediatr Emerg Care; 2010 Jan; 26(1):10-4. PubMed ID: 20042914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of children removed from a clandestine methamphetamine laboratory.
    Grant P
    J Emerg Nurs; 2007 Feb; 33(1):31-41. PubMed ID: 17258050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Children and clandestine drug laboratories: the unseen victims.
    Hawkrigg SL; Winterton PM
    Med J Aust; 2013 Dec; 199(11):739-41. PubMed ID: 24329626
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse Health Effects Associated with Living in a Former Methamphetamine Drug Laboratory - Victoria, Australia, 2015.
    Wright J; Kenneally ME; Edwards JW; Walker GS
    MMWR Morb Mortal Wkly Rep; 2017 Jan; 65(52):1470-1473. PubMed ID: 28056000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of clandestine drug laboratories: need for evidence-based environmental health policies.
    Al-Obaidi TA; Fletcher SM
    Environ Health Prev Med; 2014 Jan; 19(1):1-11. PubMed ID: 24002745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical hazards related to clandestine drug laboratories.
    Hughart JL
    Arh Hig Rada Toksikol; 2000 Sep; 51(3):305-10. PubMed ID: 11148935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clandestine drug laboratory situation in the United States.
    Frank RS
    J Forensic Sci; 1983 Jan; 28(1):18-31. PubMed ID: 6680736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evolving problem: methamphetamine production and trafficking in the United States.
    Shukla RK; Crump JL; Chrisco ES
    Int J Drug Policy; 2012 Nov; 23(6):426-35. PubMed ID: 22943831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hazards of illicit methamphetamine production and efforts at reduction: data from the hazardous substances emergency events surveillance system.
    Melnikova N; Welles WL; Wilburn RE; Rice N; Wu J; Stanbury M
    Public Health Rep; 2011; 126 Suppl 1(Suppl 1):116-23. PubMed ID: 21563719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public health consequences among first responders to emergency events associated with illicit methamphetamine laboratories--selected states, 1996-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Nov; 49(45):1021-4. PubMed ID: 11098778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute public health consequences of methamphetamine laboratories--16 states, January 2000-June 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Apr; 54(14):356-9. PubMed ID: 15829865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine.
    Vearrier D; Greenberg MI; Miller SN; Okaneku JT; Haggerty DA
    Dis Mon; 2012 Feb; 58(2):38-89. PubMed ID: 22251899
    [No Abstract]   [Full Text] [Related]  

  • 15. Changing over-the-counter ephedrine and pseudoephedrine products to prescription only: impacts on methamphetamine clandestine laboratory seizures.
    Cunningham JK; Callaghan RC; Tong D; Liu LM; Li HY; Lattyak WJ
    Drug Alcohol Depend; 2012 Nov; 126(1-2):55-64. PubMed ID: 22592141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are methamphetamine precursor control laws effective tools to fight the methamphetamine epidemic?
    Nonnemaker J; Engelen M; Shive D
    Health Econ; 2011 May; 20(5):519-31. PubMed ID: 21433216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anhydrous ammonia thefts and releases associated with illicit methamphetamine production--16 states, January 2000-June 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Apr; 54(14):359-61. PubMed ID: 15829866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing environmental prevention strategies for reducing the prevalence and associated harms of methamphetamine use.
    Yacoubian GS
    J Drug Educ; 2007; 37(1):31-53. PubMed ID: 17982934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidemiology of methamphetamine use and harm in Australia.
    Degenhardt L; Roxburgh A; Black E; Bruno R; Campbell G; Kinner S; Fetherston J
    Drug Alcohol Rev; 2008 May; 27(3):243-52. PubMed ID: 18368605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial degradation of illicit drugs, their precursors, and manufacturing by-products: implications for clandestine drug laboratory investigation and environmental assessment.
    Janusz A; Kirkbride KP; Scott TL; Naidu R; Perkins MV; Megharaj M
    Forensic Sci Int; 2003 Jun; 134(1):62-71. PubMed ID: 12842360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.